Smart harness alerts visually impaired people to obstacles in their paths

Article

According to the company, biped.ai includes a comfortable and lightweight collar fitted with 3D cameras that continuously monitor a 170° field of view for the user detecting, tracking and predicting the trajectories of all surrounding elements a few seconds in advance.

The biped.ai smart harness. Image courtesy of biped

The biped.ai smart harness. Image courtesy of biped.

Swiss-start-up biped recently demonstrated its AI-co-pilot for blind and visually impaired people during the Consumer Electronics Show 2022 in Las Vegas.

According to the company, biped.ai includes a comfortable and lightweight collar fitted with 3D cameras that continuously monitor a 170° field of view for the user detecting, tracking and predicting the trajectories of all surrounding elements a few seconds in advance. It then filters the relevant information and warns the wearer via immersive 3D sounds.

“This mirrors the way autonomous vehicles work,” CEO and co-founder Mael Fabien said in a statement. “biped will, for example, warn a user about a bike 12 meters ahead on the user’s trajectory, but ignore an object that is closer but with no collision risk.”

According to the release, biped was formed in January 2021 after Fabien met his co-founder and CTO Bruno Vollmer at the International Create Challenge hackathon in Switzerland.

“I was both inspired by my research and by working next to the main ophthalmic hospital in Lausanne,” Fabien said in the release. “Every day I would encounter blind and visually impaired people and wondered if we could go beyond sticks and guide-dogs to help them.”

Further research revealed that only 5% of the estimated 5 million fully blind people in Europe and the US would take up the option of a guide-dog. Furthermore, the biped team also discovered that younger people are interested in solutions that are less stigmatizing than a stick.

Fabien pointed out that the company worked extensively with trialists on the user-friendliness of biped and the model shown recently at CES incorporates their feedback. The collar weighs under 1 kg and can be worn over any thickness of clothing – from t-shirts to parkas – and has no clips or special fastenings. It also looks like a rucksack strap rather than a medical device. The signals are transmitted through comfortable bone conduction earphones and the system can also connect to mobile apps to use GPS.”

According to the company, it recently closed a $1.1 million seed round from Swiss and French business angels and a Swiss VC and is now filing for Class I medical device status.

Fabien added that the company’s goal is to launch first in Switzerland in Q2 and then the US in early 2023.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.